On the heels of the 44th Annual J.P. Morgan Health Care Conference, Troutman Pepper Locke attorneys Joe Kadlec and Emma Trivax discuss how AI, shifting regulatory scrutiny, and evolving investor oversight are reshaping health care transactions and preview what dealmakers should expect in 2026.